ESMO Breast Cancer 2023 Congress Coverage

 

ESMO Breast Cancer 2023 Congress Coverage
H

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients Who Discontinued Chemo Before Pembro and in Patients With Immune-Mediated AEs

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Hope Rugo
By ESMO Breast Cancer 2023 Congress Coverage FEATURING Hope Rugo
868 views
May 25, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
Videos
19:34

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

ESMO Breast Cancer 2023 Congress Coverage

H. McArthur

161 views
10:48

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…

ESMO Breast Cancer 2023 Congress Coverage

M. Oliveira

307 views
16:20

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…

ESMO Breast Cancer 2023 Congress Coverage

S. Lee

122 views
07:49

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

868 views
17:44

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

51 views
14:38

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…

ESMO Breast Cancer 2023 Congress Coverage

K. Gelmon

106 views
17:03

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…

ESMO Breast Cancer 2023 Congress Coverage

C. Criscitiello

263 views
10:06

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …

ESMO Breast Cancer 2023 Congress Coverage

T. Tan

51 views
14:11

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

ESMO Breast Cancer 2023 Congress Coverage

P. Tarantino

768 views
16:58

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…

ESMO Breast Cancer 2023 Congress Coverage

J. Balko

45 views
09:56

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …

ESMO Breast Cancer 2023 Congress Coverage

J. Cortes

502 views
05:47

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…

ESMO Breast Cancer 2023 Congress Coverage

S. Lammers

54 views